Elmiron When Clients Can't Afford To Lose, Choose Sultzer & Lipari

Elmiron Lawsuits & Mass Torts

Nationwide Elmiron Litigation Attorneys

The urinary disorder medication Elmiron has been linked to a degenerative eye disease that can result in vision loss, especially after long-term use. Patients who have been prescribed Elmiron have begun filing lawsuits, class actions, and mass torts against Janssen Pharmaceuticals, the Big Pharma company and subsidiary of Johnson & Johnson (J&J) that manufacturers the drug. If you have used Elmiron and have since been diagnosed with a vision disorder or eye disease, then you should be doing the same.

Sultzer & Lipari can help you discover your rights and legal options after being hurt due to Elmiron use. Our lawyers are capable of providing in-depth representation – including up to settlement negotiations and litigation – for clients throughout the state and beyond. Due to the collective nature of mass torts and class actions, we might be able to provide legal assistance even if you do not live in New York.

Get more information about Elmiron lawsuits by dialing (800) 552-0265 and requesting a consultation.

What Elmiron is Supposed to Treat

Elmiron – or pentosan polysulfate sodium in general drug terms – is meant to primarily treat interstitial cystitis (IC). Most patients take 300 milligrams of the drug per day for months, years, or until the worst symptoms of the urinary tract and bladder disorder are alleviated. However, the American Academy of Ophthalmology (AAO) revealed in 2019 its scientific findings that extended use of Elmiron was the most dangerous, as patients were at a higher and higher risk of developing pigmentary maculopathy the more often that they used the pharmaceutical.

Vision Loss Due to Pigmentary Maculopathy

The long-term or repeated use of Elmiron has been linked to an extremely rare degenerative eye disorder: pigmentary maculopathy. In fact, this eye disease is so rare that the AAO believes it is caused specifically by Elmiron use. Pigmentary maculopathy causes eye pigmentation to darken and spots to form on the eye’s macula, which can result in visual acuity loss.

Some of the worst symptoms of pigmentary maculopathy are:

Blindness
Dark spots in vision
Inability to read without eye pain
Blurriness at varying distances

The link between Elmiron and pigmentary maculopathy seems to be significant, based on the AAO findings and other studies that the group researched. At this time, it is estimated that upwards of 25% of Elmiron users will experience vision loss to some degree.

Should You Stop Taking Elmiron?

Elmiron was approved by the U.S. Food and Drug Administration (FDA) in 1996. It has not been recalled by the FDA or Janssen Pharmaceuticals yet, though.

If you are taking Elmiron, then you should speak to your doctor as soon as possible about seeking an alternative medicine to treat your interstitial cystitis. It is not advised that you stop using a prescription drug without proper consultation with a trusted medical provider who approves a new medication first.

Why Janssen Pharmaceuticals Might Be Liable

Prescription drugs often have dangerous side effects, but that circumstance alone does not warrant a lawsuit or mass tort being filed against drug companies. The reason why Janssen Pharmaceuticals might be liable for the harm caused by Elmiron is because the risk of vision loss has not been disclosed to doctors, patients, or the public. At this time, product packaging for Elmiron has not been updated to warn of the seemingly high risk of pigmentary maculopathy.

The failure to properly test a drug as it is being manufactured followed by the failure to warn of known side effects constitute the need for legal action against Janssen Pharmaceuticals and J&J. This level of intentional or inadvertent professional negligence is unacceptable, especially when so many patients have already been seriously injured by long-term Elmiron use.

Damages that the drug companies might be liable for include:

Cost of all medical care associated with a patient vision loss
Cost of lifestyle changes to accommodate a blinded patient
Lost wages due to being unable to keep gainful employment after blindness
Suffering and lessened enjoyment of life due to blindness

Should You File an Elmiron Lawsuit? Find Out Today

Filing a lawsuit against a Big Pharma company is never easy and joining a class action or mass tort is complicated. Should you be doing either if you have taken Elmiron and have suffered measurable vision loss? Rather than guessing, get a sure answer by working with Sultzer & Lipari and our Elmiron lawsuit attorneys. During your initial consultation, we can determine if you have a valid claim and, if so, whether your case should be prepared as part of a mass tort against J&J.

Get the answers you need by calling (800) 552-0265 now. Remember: We might be able to work with clients outside of New York.

Continue Reading Read Less

Contact Our Firm

First Name
Please enter your first name.
Last Name
Please enter your last name.
Phone
Please enter your phone number.

This isn't a valid phone number.
Email
Please enter your email address.

This isn't a valid email address.
Address
Please lookup your address.
Are you a new customer?
Please make a selection.
How can we help you?
Please enter a message.
By submitting, you agree to be contacted about your request & other information using automated technology. Message frequency varies. Msg & data rates may apply. Text STOP to cancel. Acceptable Use Policy

Our Testimonials

Hear from Our Clients, Peers, and Judges Across the Country

"Swetz v. The Clorox Company, Case No. 22-CV-9374 (S.D.N.Y)"
I'm delighted that you were able to resolve this. I think very highly of lawyers who actually take on these matters.

- Judge Philip M. Halpern - United States District Court for the Southern District of New York
"See Patora v. Tarte, Inc., Case No. 18-cv-11760-KMK (S.D.N.Y.)"
The Sultzer Firm has many highly-qualified and capable and experienced lawyers representing plaintiffs in consumer class actions.

- Judge Kenneth M. Karas - United States District Court for the Southern District of New York
"Arredondo v. University of La Verne, Case No. 2:20-cv-07665 (C.D. Cal.)"
Counsel has demonstrated strong knowledge of the applicable law throughout the briefing process for this class certification motion.

- Judge Mark C. Scarsi - United States District Court for the Central District of California
"Susan Swetz et al v. GSK Consumer Health, Inc., Case No. 7:20-cv-04731 (S.D.N.Y.)"
Class Counsel have prosecuted the Litigation with skill, perseverance, and diligence, as reflected by the Settlement Fund achieved.

- Judge Román - United States District Court for the Southern District of New York
"Shiv Patel v. St. John’s University, Case No. 1:20-cv-02114 (E.D.N.Y.)"
The firms’ expertise and competency in the class action context are reflected by the favorable outcomes.

- Judge Gold - United States District Court for the Eastern District of New York
"Griffin, Anthony, et al., v. Aldi, Inc., Doe Defendants 1-10, Case No. 16-cv-00354 (N.D.N.Y.)"
Plaintiffs’ Counsel have worked diligently and are experienced and well-versed in wage and hour cases and class actions.

- Judge Lawrence E. Kahn - United States District Court for the Northern District of New York
"My research found that he is the best in his field."
My research found that he is the best in his field.

- John
"Bangoura v. Beiersdorf, Inc., Case No. 1:22-cv-291, ECF No. 40 (E.D.N.Y. Jan. 10, 2023)"
Judge Cogan stated that “the fact that I’m looking at 2022 index number on this case is, in itself, a testament to the efficiency of plaintiffs’ counsel’s efforts.”

- Judge Brian M. Cogan - United States District Court for the Eastern District of New York

View All

A Record that Speaks for Itself

Over A Billion Dollars Won for Injured or Defrauded Clients

$1.3 Billion Automobile Defect
$22.5 Million Brain Injury Case
$10 Million Brain Injury Case
$3.5 Million Burn Injury Case
Burn Injury Case

View All Results

Why Choose Our Firm?

The Right Firm Can Make the Difference

Client-Centered Commitment
At Sultzer & Lipari, we place our clients at the heart of everything we do. Our dedicated team ensures personalized attention and tailored legal strategies to meet each client's unique needs, ensuring the best possible outcomes in every case.
Leaders in Class Actions

Sultzer & Lipari is one of the most sophisticated and successful class action firms in the country, recovering hundreds of millions of dollars for aggrieved consumers, employees, investors and small businesses nationwide.
Impeccable Reputation
Our attorneys are renowned by clients, courts, and adversaries for their creativity and tenacity in the courtroom.
Experience on Your Side

The seasoned trial attorneys at Sultzer & Lipari possess over 100 years of collective experience in complex civil disputes.
Trial-Tested Advocacy
Our attorneys have an unparalleled record of victories in complex commercial litigation & class action cases in nearly every state throughout the country.
A Prolific Record of Results
We have recovered over $1 billion for injured or defrauded clients, winning virtually every case we've tried or obtaining a superb settlement along the way.